poisar

Stock

ProQR Therapeutics N.V. PRQR

$1.56-13.81%

Overview

PRQR market data

Price History

PRQR price chart

Valuation & Profitability

no valuation data
No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for PRQR. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

5 captured
ProQR Therapeutics Files Prospectus For Offering 3.03M Ordinary Shares On Behalf Of Selling ShareholderBenzinga · Jul 6, 2026, 8:15 PM
Evercore ISI Group Maintains Outperform on ProQR Therapeutics, Raises Price Target to $6Benzinga · Jun 29, 2026, 3:05 PM
ON Semiconductor To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For FridayBenzinga · Jun 26, 2026, 1:20 PM
Chardan Capital Maintains Buy on ProQR Therapeutics, Lowers Price Target to $3Benzinga · Jun 26, 2026, 12:55 PM
Small-Cap ProQR Therapeutics Secures Funding From Eli Lilly On Early Trial SuccessBenzinga · Jun 25, 2026, 2:01 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock